Phibro Animal Health (PAHC) Other Accumulated Expenses (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Other Accumulated Expenses came in at $29.9 million in Q1 2026, down 28.44% year-on-year from $41.7 million in Q1 2025, and up 1480.42% quarter-over-quarter from $1.9 million in Q4 2025.
Phibro Animal Health (PAHC) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Phibro Animal Health's Other Accumulated Expenses history runs 10 years deep, the most recent figure standing at $29.9 million for Q1 2026.
- On a quarterly basis, Other Accumulated Expenses fell 28.44% year-over-year to $29.9 million in Q1 2026; TTM through Mar 2026 was $29.9 million, a 28.44% decrease from a year earlier, with the FY2025 full-year figure at $1.7 million, down 90.56% from the prior year.
- Other Accumulated Expenses improved to $29.9 million in Q1 2026 per PAHC's latest filing, from $1.9 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $41.7 million in Q1 2025 and bottomed at $1.2 million in Q1 2022.
- The 5-year median for Other Accumulated Expenses is $17.5 million (2024), against an average of $12.5 million.
- Biggest YoY gain for Other Accumulated Expenses was 1562.26% in 2023; the steepest drop was 92.64% in 2023.
- Year by year, Other Accumulated Expenses stood at $18.5 million in 2022, then slumped by 92.64% to $1.4 million in 2023, then grew by 6.46% to $1.4 million in 2024, then jumped by 30.34% to $1.9 million in 2025, then jumped by 1480.42% to $29.9 million in 2026.
- Per Business Quant, the three latest PAHC Other Accumulated Expenses figures stand at $29.9 million (Q1 2026), $1.9 million (Q4 2025), and $1.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.34 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.87 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 41.74 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 18.19 Mn |
| Jun 30, 2024 | 17.54 Mn |
| Mar 31, 2024 | 17.75 Mn |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 1.36 Mn |
| Jun 30, 2023 | 18.86 Mn |
| Mar 31, 2023 | 19.60 Mn |
| Dec 31, 2022 | 18.52 Mn |
| Sep 30, 2022 | 1.22 Mn |
| Jun 30, 2022 | 18.90 Mn |
| Mar 31, 2022 | 1.18 Mn |
| Dec 31, 2021 | 1.22 Mn |
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.18 Mn |